Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Protective effect of EGb761 against Aβ1-42 -induced SH-SY5Y cells injury and blood-brain barrier disruption via regulating Akt/Nrf2 signaling pathway

Liling Wang¹, Jianhua Mi¹, Yeping Song¹, Pengfei Wang²

¹Department of Neurology; ²Department of Cardiology, South Campus of Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 201112, China.

For correspondence:- Pengfei Wang Email: hjv7856@126.com Tel:+8618290772017

Accepted: 29 May 2020 Published: 30 September 2021

Citation: Wang L, Mi J, Song Y, Wang P. Protective effect of EGb761 against Aβ1-42 -induced SH-SY5Y cells injury and blood-brain barrier disruption via regulating Akt/Nrf2 signaling pathway. Trop J Pharm Res 2021; 20(9):1811-1818 doi: 10.4314/tjpr.v20i9.5

© 2021 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: Alzheimer’s disease (AD) is a common disease in the world caused by deposition in the brain parenchyma, accumulation of beta amyloid which leads to the blood brain barrier (BBB) disruption. Regardless of enough progress in the treatment of AD, the principal mechanism of BBB injury is yet not clear.

Methods: In this study we examined the impact of EGb761on Aβ 1-42-induced SH-SY5Y cells in vitro model of AD. Cell viability was assessed by using MTT assay, flow cytometry was used to check the rate of cell apoptosis, ROS generation and BBB leakage was assessed by measuring the level of fluorescence in Aβ-induced SH-SY5Y cells using a reactive oxygen species kit assay and BBB permeability assay, and mRNA levels of Bax, Bcl-2, caspase-3 was measured by using RT-qPCR. Furthermore, western blot analysis was used to measure the protein expressions of Akt, Nrf2 and HO-1 in Aβ 1-42-induced SH-SY5Y cells.

Results: The effect of EGb761 was investigated on the cell apoptosis induced by Aβ 1-42 and generation of ROS and we found that EGb761 plays a protective role against cell injury induced by Aβ 1-42. Cell apoptosis and ROS generation in SH-SY5Y cells decreased significantly with the treatment of EGb761. Furthermore, BBB permeability reduced considerably when the cells treated with EGb761 and the expression levels of Caspase-3 and Bax decreased while that of Bcl-2 were markedly increased in the Aβ 1-42-induced SH-SY5Y cells. Also, an increased in expression levels of p-Akt, Nrf2 (nucleus) and HO-1 was observed with the treatment of EGb761 in Aβ 1-42-induced SH-SY5Y cells.

Conclusion: It can be concluded from these results that EGb761 could play a protective role by inhibiting apoptosis and protect Aβ 1-42-induced cell injury in vitro model of AD via activating Akt/Nrf2 signaling pathway. Our study suggested that EGb761 might be a therapeutic agent for the prevention and treatment of AD.

Keywords: EGb761, oxidative stress, Alzheimer’s disease (AD), BBB, Akt/Nrf2